Investigating how new components control RNA silencing

Functions and mechanisms of new components in RNA silencing

NIH-funded research Texas A&m Agrilife Research · NIH-11003719

This study is looking at how plants, like Arabidopsis, control tiny molecules that help them manage their genes, which could lead to better crops that are stronger and more resistant to diseases, ultimately benefiting everyone.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionTexas A&m Agrilife Research NIH-funded
Lab location1 site (College Station, UNITED STATES)
Project IDNIH-11003719 on NIH RePORTER

What this research studies

This research focuses on understanding the complex mechanisms that regulate RNA silencing and processing, particularly in the plant model organism Arabidopsis. The team will explore newly identified components involved in two key regulatory hubs, Serrate (SE) and Suppressor of Gene Silencing 3 (SGS3), which play crucial roles in the production of microRNAs and small interfering RNAs. By deciphering these mechanisms, the research aims to enhance our ability to manipulate RNA silencing pathways for various biotechnological applications. Patients may benefit indirectly through advancements in agricultural biotechnology that could lead to improved crop resilience and disease resistance.

Who could benefit from this research

Good fit: Ideal candidates for participation or benefit from this research would include individuals interested in advancements in agricultural biotechnology and its implications for food production.

Not a fit: Patients with no interest in agricultural biotechnology or those not affected by agricultural practices may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to breakthroughs in biotechnology that enhance crop resilience and disease resistance, benefiting food security and agricultural health.

How similar studies have performed: Other research has shown success in understanding RNA silencing mechanisms, but this specific investigation into newly identified components is relatively novel.

Where this research is happening

College Station, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.